This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Mykhalyo Goncharenko: Innovating Anti-Inflammatory Solutions in London, CA
Introduction
Mykhalyo Goncharenko is a prominent inventor based in London, Canada, recognized for his invaluable contributions to the field of medicinal chemistry. His notable invention focuses on 2,4,5-trisubstituted thiazolyl derivatives and their anti-inflammatory activity, which holds significant promise for therapeutic applications.
Latest Patents
Mykhalyo Goncharenko holds a patent for a compound designed to address inflammatory diseases, specifically those mediated through TNF-α and IL-12. The patent encompasses various chemical structures, including N-oxides and pharmaceutically acceptable addition salts, aimed at creating effective medications to prevent or treat these conditions. The detailed chemical formula allows for diverse applications in the pharmaceutical industry, showcasing Mykhalyo's innovative approach to drug development.
Career Highlights
Currently, Mykhalyo is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company committed to addressing unmet medical needs through innovative solutions. His work has significantly contributed to the advancements in the treatment of inflammatory diseases, reflecting a strong dedication to improving patient outcomes.
Collaborations
Throughout his career, Mykhalyo has collaborated with esteemed colleagues, including Christopher John Love and Jean Pierre Frans Van Wauwe. Together, they have worked on various projects that enhance the understanding and treatment of inflammatory conditions, fostering a collaborative environment that drives innovation.
Conclusion
Mykhalyo Goncharenko exemplifies the spirit of innovation within the pharmaceutical sector. His pioneering patent for 2,4,5-trisubstituted thiazolyl derivatives stands as a testament to his expertise and commitment to improving health outcomes. As he continues to work at Janssen Pharmaceutica NV, the medical community eagerly anticipates further advancements from his research and collaborative efforts.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile